Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
AL002 Alzheimer's Disease (Phase 1) AbbVie, Alector Inflammation Immunotherapy (active)
AL003 Alzheimer's Disease (Phase 1) AbbVie, Alector Inflammation Immunotherapy (active)
DNL747 SAR 443060 Alzheimer's Disease (Phase 1), Amyotrophic Lateral Sclerosis (Phase 1) Denali Therapeutics Inc., Sanofi Inflammation Small Molecule
GC 021109 Alzheimer's Disease (Phase 1) GliaCure Inflammation Small Molecule
GENUS Gamma entrainment using sensory stimuli Alzheimer's Disease (Phase 1) Cognito Therapeutics, Inc. Amyloid-Related, Inflammation, Other Combination, Procedural Intervention
XPro1595 INB03, NeuLiv, XENP1595, DN-TNF, XENP345 Alzheimer's Disease (Phase 1) INmune Bio Inc. Inflammation Other